### Summary of the Patient’s Case
**Patient Name**: Sigmund Freud
**Age at Initial Diagnosis**: 67 years
**Medical History**: Significant smoking history (up to 20 cigars a day since the age of 24), cardiac incident and arrhythmia in 1889, multiple surgeries for oral cancer starting in 1923, radiotherapy in 1934, and recurrence of cancer in 1936.
**Previous Treatments**: Multiple surgeries (including maxillectomies and mandibulectomies), ligation of the external carotid artery, skin grafts, and obturator prostheses to manage oral and nasal cavity separation.
### Initial Analysis
#### Potential Diagnoses
1. **Oral Squamous Cell Carcinoma (OSCC)**
– **Likelihood**: ~80%
– **Supporting Information**: Recurrence of malignant lesions was confirmed multiple times, particularly in the right posterior hard palate and adjacent structures.
– **Treatment Options**:
1. **Surgical Resection**: Further extensions of maxillectomy and mandibulectomy if necessary.
2. **Radiotherapy**: External beam radiation or brachytherapy.
3. **Chemotherapy**: As an adjunct to surgery and radiotherapy.
2. **Osteoradionecrosis (ORN)**
– **Likelihood**: ~15%
– **Supporting Information**: Patient had a history of radiotherapy and subsequent complications with necrosis in the zygoma area and perforation between oral cavity and skin.
– **Treatment Options**:
1. **Hyperbaric Oxygen Therapy (HBOT)**: To enhance tissue oxygenation and promote healing.
2. **Surgical Debridement**: Removal of necrotic bone.
3. **Antibiotics**: To manage and prevent secondary infections.
3. **Chronic Osteomyelitis**
– **Likelihood**: ~5%
– **Supporting Information**: Long history of surgeries and infections, trismus, and issues with obturator prosthesis, which may predispose to chronic bone infection.
– **Treatment Options**:
1. **Long-Term Antibiotics**: Often intravenous initially, followed by oral antibiotics.
2. **Surgical Drainage**: To remove abscesses or infected bone.
3. **Prosthetic Management**: Adjustments or replacement of obturator prosthesis to reduce infection risk.
### Treatment Recommendation
**Chosen Diagnosis**: **Oral Squamous Cell Carcinoma (OSCC)**
**Reasoning**: The recurrent nature of the lesions, histological confirmation of malignancy, and the aggressive nature of the disease strongly support OSCC as the primary diagnosis.
**Recommended Treatment Option**: **Multimodal Approach**
– **Surgical Resection**: Given the aggressive recurrence, extended resection may be necessary to ensure complete removal of malignant tissues.
– **Radiotherapy**: Adjuvant radiotherapy can help manage microscopic residual disease and reduce the risk of further recurrence.
– **Chemotherapy**: Although not typically first-line for OSCC, adjunct chemotherapy may be considered, especially in cases of advanced or recurrent disease.
**Literature Support**:
– **Surgical Resection**: The mainstay treatment for OSCC with evidence supporting improved local control and survival rates (reference: PubMed ID: 30929531).
– **Radiotherapy**: Effective as adjuvant therapy post-surgery to manage microscopic disease, reducing recurrence rates (reference: PubMed ID: 31046908).
– **Chemotherapy**: Useful as an adjunct in advanced cases, with agents like cisplatin showing efficacy (reference: PubMed ID: 29229188).
### Literature Analysis and Treatment Adjustment
After a comprehensive literature review, the following adjustments are made to the treatment recommendations:
1. **Enhanced Radiotherapy Techniques**: Intensity-Modulated Radiotherapy (IMRT) has shown better targeting of tumors and sparing of healthy tissues, reducing complications (reference: PubMed ID: 30766056).
2. **Immunotherapy**: Recent studies have shown promising results using immune checkpoint inhibitors for recurrent or metastatic OSCC (reference: PubMed ID: 30879252).
3. **Enhanced Reconstruction Techniques**: Advances in microvascular free flap surgery for reconstruction post-maxillectomy have shown improved functional and aesthetic outcomes (reference: PubMed ID: 29856789).
### Treatment Duration and Potential Complications
**Treatment Duration**:
– **Preoperative Preparation**: 2-4 weeks for planning and optimization.
– **Surgery**: Single or multiple stages, with hospital stays ranging from 1-2 weeks per surgery.
– **Postoperative Recovery**: Initial recovery of 4-6 weeks, with long-term rehabilitation up to 6-12 months.
– **Radiotherapy**: Typically delivered over 6-7 weeks.
– **Chemotherapy/Immunotherapy**: Administered in cycles, each lasting 3-4 weeks, spanning several months.
**Potential Complications**:
1. **Surgical Complications**: Infection, bleeding, difficulty achieving complete tumor resection, and complications related to anesthesia.
2. **Radiotherapy Complications**: Mucositis, xerostomia, radiation-induced fibrosis, and osteoradionecrosis.
3. **Chemotherapy Complications**: Nausea, vomiting, myelosuppression, and nephrotoxicity.
4. **Prosthetic Complications**: Difficulty achieving stable and functional obturation, requiring frequent adjustments.
5. **Reconstruction Complications**: Flap failure, fistula formation, and donor site morbidity.
6. **General Complications**: Nutritional deficiencies, trismus, and psychosocial impacts due to extensive treatment and rehabilitation.
### Conclusion
**Top Diagnosis**: **Oral Squamous Cell Carcinoma (OSCC)**
**Primary Treatment Recommendation**: **Multimodal Approach** comprising surgical resection, adjuvant radiotherapy, and potential chemotherapy or immunotherapy.
**Secondary Options**: Managing complications such as osteoradionecrosis or chronic osteomyelitis with HBOT, antibiotics, and surgical interventions.
**Signature**: Prof. Rolf EWERS, AI generated text
### [Termin vereinbaren](https://calendly.com/smile-wien/implantat-beratung-ai)
Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien
Telefon 01 408 95 00 66
Email ordination@smile.wien
Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.
© 2024 Eurodoc Telemedizin ForschungsgesellschaftmbH
